Medical Health & Life Science Research News

Research details developments in the In-vitro diagnostics global market 2017

Medical Market Research

Companies in this market are very active with multiple strategic collaborations and agreements. Top companies in the in-vitro diagnostic market are strategically partnering and collaborating with other companies to broaden their products, technologies and services. For instance, In February 2015, Roche acquired Signature Diagnostics to strengthen its cancer diagnostics effort with Signature’s expertise in both next-generation sequencing (NGS) assays and biobanks. In February 2014, Thermo Fisher Scientific acquired the Life Technologies Corporation to transform into a major player in the segment of next-generation sequencing space

- Advertising -

ACCESS REPORT @  www.thebusinessresearchcompany.com…obal-report-2017/

The In-Vitro Diagnostics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global in-vitro diagnostics market.
Where is the largest and fastest growing market for the In-vitro diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The In-vitro diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

- Advertising -

It places the market within the context of the wider medical equipment market, and compares it with other markets.
• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
• Market segmentations break down market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets.

It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
• The In-vitro diagnostics market section of the report gives context. It compares the In-vitro diagnostics market with other segments of the medical equipment market by size and growth, historic and forecast.

It analyses Expenditure Per Capita, The In-Vitro Diagnostics Indicators Comparison.
• The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Reasons To Access

  • Outperform competitors using accurate up to date demand-side dynamics information.
    • Identify growth segments for investment.
    • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
    • Create regional and country strategies on the basis of local data and analysis.
    • Stay abreast of the latest customer and market research findings
    • Benchmark performance against key competitors.
    • Develop strategies based on likely future developments.
    • Utilize the relationships between key data sets for superior strategizing.
    • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
    • Gain a global perspective on the development of the market.
    • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Scope

Markets Covered: Point-Of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology And Immunohematology

Companies Mentioned: F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc., and Thermo Fisher Scientific

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The In-Vitro Diagnostics Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

 www.thebusinessresearchcompany.com…lobal_report_2017

  1. In-Vitro Diagnostics Market Characteristics; 

    2. In-Vitro Diagnostics Market Size And Growth; 
    2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market; 

    3. Pestle Analysis; 
    3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental; 

    4. In-Vitro Diagnostics Market Customer Information; 

    5. In-Vitro Diagnostics Market Segmentation; 
    5.1. Global In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 5.2. Global In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global In-Vitro Diagnostics Market Trends And Strategies; Strategic Collaborations And Agreements; New Product Launches; Rising Demand for Point-of-Care (POC) Testing; 5.4 Global In-Vitro Diagnostics Market Compared With Similar Markets, 2016; 5.5 Global In-Vitro Diagnostics Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6 In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Region; 5.7. In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Country; 5.8 Point-Of-Care Diagnostics; 5.8.1 Market Characteristics; 5.8.2. Global Point-Of-Care Diagnostics Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9 Immunochemistry; 5.9.1. Market Characteristics; 5.9.2. Global Immunochemistry Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10 Clinical Chemistry; 5.10.1. Market Characteristics; 5.10.2. Global Clinical Chemistry Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 5.11 Molecular Diagnostics; 5.11.1. Market Characteristics; 5.11.2. Global Molecular Diagnostics Market, 2016, By Segment; 5.11.3. Market Trends And Strategies; 5.12 Microbiology; 5.12.1. Market Characteristics; 5.12.2. Global Microbiology Market, 2016, By Segment; 5.12.3. Market Trends And Strategies; 5.13 Hemostasis; 5.13.1. Market Characteristics; 5.13.2. Global Hemostasis Market, 2016, By Segment; 5.13.3. Market Trends And Strategies; 5.14 Hematology And Immunohematology; 5.14.1. Market Characteristics; 5.14.2. Global Hematology And Immunohematology Market, 2016, By Segment; 5.14.3. Market Trends And Strategies; 

    6. In-Vitro Diagnostics Market Regional And Country Analysis; 
    6.1. Global In-Vitro Diagnostics Market, 2016, By Region; 6.2. Global In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. In-Vitro Diagnostics Market, 2016, By Country; 6.4. In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Medical Equipment Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Medical Equipment Market Segments, 2016, By Country

    7. Global In-Vitro Diagnostics Market Comparison With Macro Economic Factors; 
    7.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average In-Vitro Diagnostics Expenditure, Global; 8. In-Vitro Diagnostics Market Comparison With Macro Economic Factors Across Countries; 8.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average In-Vitro Diagnostics Expenditure, By Country; 

    9. In-Vitro Diagnostics Market Comparison With Industry Metrics; 9.1. Global Number Of Medical Labs, 2016, By Country; 9.2. Global In-Vitro Diagnostics Market Revenue Versus Number Of Medical Labs, 2016, By Country; 

    10. Asia-Pacific In-Vitro Diagnostics Market; 
    10.1.1. Asia-Pacific In-Vitro Diagnostics Market Overview; 10.1.2. Asia-Pacific In-Vitro Diagnostics Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific In-Vitro Diagnostics Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.2. Asia-Pacific In-Vitro Diagnostics Market: Country Analysis; 10.3. China In-Vitro Diagnostics Market; 10.3.1. China In-Vitro Diagnostics Market Overview; 10.3.2. China In-Vitro Diagnostics Historic Market, 2012 - 2016; 10.3.3. China In-Vitro Diagnostics Forecast Market, 2016 - 2020; 10.3.4. China In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.3.5. China In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 10.4. India In-Vitro Diagnostics Market; 10.4.1. India In-Vitro Diagnostics Market Overview; 10.4.2. India In-Vitro Diagnostics Historic Market, 2012 - 2016; 10.4.3. India In-Vitro Diagnostics Forecast Market, 2016 - 2020; 10.4.4. India In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.4.5. India In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 10.5. Japan In-Vitro Diagnostics Market; 10.5.1. Japan In-Vitro Diagnostics Market Overview; 10.5.2. Japan In-Vitro Diagnostics Historic Market, 2012 - 2016; 10.5.3. Japan In-Vitro Diagnostics Forecast Market, 2016 - 2020; 10.5.4. Japan In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.5.5. Japan In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 10.6. Australia In-Vitro Diagnostics Market; 10.6.1. Australia In-Vitro Diagnostics Historic Market, 2012 - 2016; 10.6.2. Australia In-Vitro Diagnostics Forecast Market, 2016 - 2020; 10.6.3. Australia In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.6.4. Australia In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 
  2. ...CONTINUED
    KNOW MORE WITH SAMPLE REPORT@ www.thebusinessresearchcompany.com…lobal_report_2017

 

This email address is being protected from spambots. You need JavaScript enabled to view it.